Literature DB >> 12712009

New approaches for the treatment of refractory meningiomas.

Brian Ragel1, Randy L Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12712009     DOI： 10.1177/107327480301000206

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  10 in total

1.  Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.

Authors:  Okay Saydam; Ozlem Senol; Tieneke B M Schaaij-Visser; Thang V Pham; Sander R Piersma; Anat O Stemmer-Rachamimov; Thomas Wurdinger; Saskia M Peerdeman; Connie R Jimenez
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

2.  Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.

Authors:  Camila Batista de Oliveira Silva; Bárbara Roberta Ongaratti; Geraldine Trott; Taiana Haag; Nelson Pires Ferreira; Carolina Garcia Soares Leães; Julia Fernanda Semmelmann Pereira-Lima; Miriam da Costa Oliveira
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

3.  Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.

Authors:  Marc C Chamberlain; Sandra K Johnston
Journal:  J Neurooncol       Date:  2011-02-13       Impact factor: 4.130

Review 4.  Aberrant signaling pathways in meningiomas.

Authors:  Brian T Ragel; Randy L Jensen
Journal:  J Neurooncol       Date:  2010-09-14       Impact factor: 4.130

5.  Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67.

Authors:  Ramesh Babu Telugu; Amit Kumar Chowhan; Nandyala Rukmangadha; Rashmi Patnayak; Bobbidi Venkata Phaneendra; Bodapati Chandra Mowliswara Prasad; Mandyam Kumaraswamy Reddy
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 6.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

7.  Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature.

Authors:  Jay Jagannathan; Rod J Oskouian; Hian Kwang Yeoh; Dwight Saulle; Aaron S Dumont
Journal:  Skull Base       Date:  2008-05

8.  Molecular signatures define two main classes of meningiomas.

Authors:  Lucia Helena Carvalho; Ivan Smirnov; Gilson S Baia; Zora Modrusan; Justin S Smith; Peter Jun; Joseph F Costello; Michael W McDermott; Scott R Vandenberg; Anita Lal
Journal:  Mol Cancer       Date:  2007-10-15       Impact factor: 27.401

Review 9.  Emerging Medical Treatments for Meningioma in the Molecular Era.

Authors:  Fares Nigim; Hiroaki Wakimoto; Ekkehard M Kasper; Linda Ackermans; Yasin Temel
Journal:  Biomedicines       Date:  2018-08-06

Review 10.  Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition.

Authors:  Sushmita Patra; Rout George Kerry; Ganesh Kumar Maurya; Bijayananda Panigrahi; Swati Kumari; Jyoti Ranjan Rout
Journal:  Front Microbiol       Date:  2020-10-20       Impact factor: 5.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.